A new public-private partnership to address inappropriate antibiotic use and antimicrobial resistance (AMR) through wider use of rapid diagnostics was launched today at an event in Madrid.
A survey of physician attitudes about antibiotic use in clinic settings found that nearly all agree that antimicrobial resistance (AMR) is a national problem, but only 63% thought the issue is a problem at their own facilities. A group based at Wayne State University reported its findings yesterday in the American Journal of Infection Control.
A randomized controlled trial of rapid diagnostics technology in two hospitals in Vietnam found no improvement in antimicrobial therapy compared with traditional microbiologic methods, according to a study in the Journal of Infection.
Iranian investigators have discovered a high rate of methicillin-resistant Staphylococcus aureus (MRSA), a common superbug, in two types of cockroaches found in hospitals, according to a study yesterday in Antimicrobial Resistance & Infection Control.
Today three federal agencies announced a partnership to advance the rapid development and deployment of diagnostic tests in US laboratories during public health emergencies.
A protocol involving urinalysis, absolute neutrophil count, and procalcitonin levels showed 97.7% sensitivity and 60.0% specificity.
Electronically delivered prescribing feedback and decision support interventions reduced antibiotic prescribing for respiratory infection (RTI) in adults by 12%, according to the results of a clinical trial published this week in the British Medical Journal.
A New York resident who drank raw milk from a Pennsylvania dairy has contracted the nation's third known case of brucellosis caused by the antibiotic-resistant Brucella RB51 strain, the Centers for Disease Control and Prevention (CDC) said yesterday in a Health Alert Network (HAN) notice. The previous two illnesses occurred in 2017.
Ethiopian researchers report that the introduction of a rapid molecular diagnostic test at a teaching hospital resulted in the first diagnosis of viral meningitis in routine clinical practice in Ethiopia. The study was published yesterday in BMC Infectious Diseases.
US scientists report that the Etest, made by the French company bioMerieux, outperformed disc tests and is a suitable alternative to broth microdilution (BMD) for testing ceftazidime combined with avibactam against ceftazidime- and meropenem-resistant Klebsiella pneumoniae, according to results published yesterday in the Journal of Antimicrobial Chemotherapy.